{"id":51176,"date":"2023-09-20T09:18:19","date_gmt":"2023-09-20T09:18:19","guid":{"rendered":"https:\/\/medsname.com\/tenvir-em\/"},"modified":"2026-05-21T05:27:39","modified_gmt":"2026-05-21T05:27:39","slug":"tenvir-em","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/tenvir-em\/","title":{"rendered":"Tenvir Em"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Tenvir-EM?<\/h3>\n<p style=\"margin:0;\"><strong>Tenvir-EM<\/strong> je tableta s fixn\u00ed kombinac\u00ed <strong>tenofovir disoproxil fumar\u00e1t (TDF) 300 mg<\/strong> a <strong>emtricitabin (FTC) 200 mg<\/strong>. Pou\u017e\u00edv\u00e1 se k <strong>HIV pre-expozi\u010dn\u00ed profylaxe (PrEP)<\/strong> prevenci sexu\u00e1ln\u011b p\u0159enosn\u00e9 infekce HIV jako sou\u010d\u00e1st <strong>kombinovan\u00e1 l\u00e9\u010dba HIV<\/strong>, a v <strong>HIV post-expozi\u010dn\u00ed profylaxe (PEP)<\/strong>. Vyrobeno spole\u010dnost\u00ed <strong>Cipla<\/strong> jako generick\u00fd ekvivalent p\u0159\u00edpravku Gilead <strong>Truvada<sup>\u00ae<\/sup><\/strong>. Jedna tableta jednou denn\u011b; p\u0159ed zah\u00e1jen\u00edm PrEP je nutn\u00e9 potvrdit HIV-negativn\u00ed status a funkci ledvin.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> Dod\u00e1v\u00e1no od v\u00fdrobce certifikovan\u00e9ho WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 <a href=\"\/cs\/reviews\/\" rel=\"noopener\">1 400+ ov\u011b\u0159en\u00fdch recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Objedn\u00e1v\u00e1n\u00ed z MedsBase v\u00e1m zaji\u0161\u0165uje dod\u00e1vky od v\u00fdrobce certifikovan\u00e9ho WHO-GMP, diskr\u00e9tn\u00ed balen\u00ed v oby\u010dejn\u00e9 ob\u00e1lce, celosv\u011btovou dopravu a hodnocen\u00ed 4,9\u2605 od v\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch z\u00e1kazn\u00edk\u016f. Platby kartou jsou sm\u011brov\u00e1ny p\u0159es regulovan\u00fd krypto-on-ramp \u2014 popis na v\u00fdpisu z va\u0161eho bankovn\u00edho \u00fa\u010dtu bude obsahovat jm\u00e9no procesoru (regulovan\u00e9ho procesoru plateb kartou), nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku. Ka\u017ed\u00e1 z\u00e1silka je pokryta na\u0161\u00edm <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.<\/p>\n<p><strong>Tenvir-EM<\/strong> je <strong>tabletka s fixn\u00ed d\u00e1vkou dvou antiretrovirov\u00fdch l\u00e1tek<\/strong> kombinuj\u00edc\u00ed <strong>tenofovir disoproxil fumar\u00e1t (TDF) 300 mg<\/strong> a <strong>emtricitabin (FTC) 200 mg<\/strong>. Je vyr\u00e1b\u011bna spole\u010dnost\u00ed <strong>Cipla<\/strong> podle farmaceutick\u00fdch norem a obsahuje stejn\u00e9 \u00fa\u010dinn\u00e9 l\u00e1tky jako origin\u00e1ln\u00ed p\u0159\u00edpravek spole\u010dnosti Gilead Sciences <strong>Truvada<sup>\u00ae<\/sup><\/strong> \u2014 za zlomek ceny. Ka\u017ed\u00e1 tableta se u\u017e\u00edv\u00e1 jednou denn\u011b, s j\u00eddlem nebo bez n\u011bj.<\/p>\n<p>Tenvir-EM m\u00e1 t\u0159i hlavn\u00ed klinick\u00e9 pou\u017eit\u00ed: <strong>HIV pre-expozi\u010dn\u00ed profylaxe (PrEP)<\/strong>, <strong>kombinovan\u00e1 l\u00e9\u010dba HIV<\/strong>, a <strong>HIV post-expozi\u010dn\u00ed profylaxe (PEP)<\/strong>. Je za\u0159azen na <strong>Modelov\u00fd seznam z\u00e1kladn\u00edch l\u00e9\u010div WHO<\/strong> a tvo\u0159\u00ed z\u00e1klad v\u011bt\u0161iny glob\u00e1ln\u00edch program\u016f PrEP, v\u010detn\u011b programu CDC ve Spojen\u00fdch st\u00e1tech.<\/p>\n<h2 class=\"wp-block-heading\">Co je Tenvir-EM?<\/h2>\n<p>Tenvir-EM je kombinac\u00ed dvou <strong>nukleos(t)idov\u00fdch inhibitor\u016f reverzn\u00ed transkript\u00e1zy (NRTI)<\/strong>:<\/p>\n<ul>\n<li><strong>Tenofovir disoproxil fumar\u00e1t (TDF)<\/strong> \u2014 nukleotidov\u00fd analog, kter\u00fd blokuje HIV reverzn\u00ed transkript\u00e1zu<\/li>\n<li><strong>Emtricitabin (FTC)<\/strong> \u2014 cytidinov\u00fd analog, kter\u00fd tak\u00e9 blokuje reverzn\u00ed transkript\u00e1zu a p\u016fsob\u00ed synergicky s TDF<\/li>\n<\/ul>\n<p>P\u0159i pravideln\u00e9m u\u017e\u00edv\u00e1n\u00ed vytv\u00e1\u0159\u00ed Tenvir-EM v genit\u00e1ln\u00edch, rekt\u00e1ln\u00edch a krevn\u00edch tk\u00e1n\u00edch dostate\u010dn\u011b vysok\u00e9 intracelul\u00e1rn\u00ed hladiny l\u00e9\u010diva, aby zabr\u00e1nil HIV v navozen\u00ed infekce po expozici \u2014 nebo potla\u010dil replikaci HIV u ji\u017e infikovan\u00e9 osoby (p\u0159i pou\u017eit\u00ed jako sou\u010d\u00e1st t\u0159\u00edl\u00e9\u010debn\u00e9ho re\u017eimu).<\/p>\n<p>Tenvir-EM je indikov\u00e1n k:<\/p>\n<ul>\n<li><strong>profylaxi p\u0159ed expozic\u00ed HIV-1 (PrEP)<\/strong> \u2014 u HIV-negativn\u00edch dosp\u011bl\u00fdch s v\u00fdrazn\u00fdm rizikem n\u00e1kazy HIV<\/li>\n<li><strong>postexpozi\u010dn\u00ed profylaxe HIV-1 (PEP)<\/strong> \u2014 jako sou\u010d\u00e1st 28denn\u00edho trojkombina\u010dn\u00edho re\u017eimu po podez\u0159en\u00ed na expozici HIV<\/li>\n<li><strong>kombinovan\u00e1 l\u00e9\u010dba HIV-1<\/strong> \u2014 jako NRTI z\u00e1klad spole\u010dn\u011b s t\u0159et\u00edm \u010dinidlem (inhibitor integr\u00e1zy, NNRTI nebo boostovan\u00fd inhibitor prote\u00e1zy)<\/li>\n<li><strong>chronick\u00e1 hepatitida B<\/strong> \u2014 mimo schv\u00e1lenou indikaci, ale klinicky b\u011b\u017en\u00e9, proto\u017ee TDF je u jin\u00fdch p\u0159\u00edpravk\u016f schv\u00e1len pro monoterapii HBV<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Jak funguje Tenvir-EM?<\/h2>\n<p>Jak TDF, tak FTC jsou <strong>prol\u00e9\u010diva<\/strong> kter\u00e9 jsou uvnit\u0159 bun\u011bk fosforylov\u00e1ny na sv\u00e9 aktivn\u00ed trifosf\u00e1tov\u00e9 formy:<\/p>\n<ul>\n<li>Intracelul\u00e1rn\u00ed tenofovir difosf\u00e1t a emtricitabin trifosf\u00e1t sout\u011b\u017e\u00ed s p\u0159irozen\u00fdmi nukleotidy o za\u010dlen\u011bn\u00ed do rostouc\u00edho \u0159et\u011bzce HIV DNA<\/li>\n<li>Po za\u010dlen\u011bn\u00ed p\u016fsob\u00ed jako <strong>termin\u00e1tory \u0159et\u011bzce<\/strong> \u2014 reverzn\u00ed transkript\u00e1za HIV nem\u016f\u017ee prodlou\u017eit \u0159et\u011bzec DNA, tak\u017ee virov\u00fd genom se nem\u016f\u017ee replikovat<\/li>\n<li>P\u0159i pravideln\u00e9m denn\u00edm d\u00e1vkov\u00e1n\u00ed dosahuj\u00ed hladiny l\u00e9ku v rekt\u00e1ln\u00ed tk\u00e1ni ochrann\u00fdch koncentrac\u00ed p\u0159ibli\u017en\u011b za <strong>7 dnech<\/strong> a v pochv\u011b p\u0159ibli\u017en\u011b do <strong>20 dn\u016f<\/strong><\/li>\n<li>Klinick\u00e9 studie (iPrEx, Partners PrEP, PROUD) ukazuj\u00ed, \u017ee p\u0159i pravideln\u00e9m u\u017e\u00edv\u00e1n\u00ed p\u0159\u00edpravku Tenvir-EM doch\u00e1z\u00ed ke sn\u00ed\u017een\u00ed rizika n\u00e1kazy HIV pohlavn\u00edm stykem o v\u00edce ne\u017e <strong>99%<\/strong><\/li>\n<\/ul>\n<p>PrEP je nej\u00fa\u010dinn\u011bj\u0161\u00ed p\u0159i denn\u00edm u\u017e\u00edv\u00e1n\u00ed. Vynechan\u00e9 d\u00e1vky sni\u017euj\u00ed ochranu, zejm\u00e9na p\u0159i vagin\u00e1ln\u00edm styku, kde je vst\u0159eb\u00e1v\u00e1n\u00ed l\u00e9ku do tk\u00e1n\u011b pomalej\u0161\u00ed ne\u017e p\u0159i styku rekt\u00e1ln\u00edm.<\/p>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>profylaxi p\u0159ed expozic\u00ed HIV-1 (PrEP)<\/strong> \u2013 mu\u017ei maj\u00edc\u00ed sex s mu\u017ei, serodiscordantn\u00ed p\u00e1ry, transgender osoby, lid\u00e9 u\u017e\u00edvaj\u00edc\u00ed injek\u010dn\u00ed drogy a jak\u00fdkoli HIV-negativn\u00ed dosp\u011bl\u00fd s trval\u00fdm sexu\u00e1ln\u00edm rizikem<\/li>\n<li><strong>postexpozi\u010dn\u00ed profylaxe HIV-1 (PEP)<\/strong> \u2013 v kombinaci s t\u0159et\u00ed l\u00e1tkou (obvykle inhibitorem integr\u00e1zy jako dolutegravir nebo raltegravir) po dobu 28 dn\u016f po podez\u0159en\u00ed na expozici HIV. Mus\u00ed b\u00fdt zah\u00e1jena do <strong>72 hodin<\/strong> od expozice; \u010d\u00edm d\u0159\u00edve, t\u00edm l\u00e9pe<\/li>\n<li><strong>kombinovan\u00e1 l\u00e9\u010dba HIV-1<\/strong> \u2013 NRTI z\u00e1klad s t\u0159et\u00ed l\u00e1tkou<\/li>\n<li><strong>chronick\u00e1 hepatitida B<\/strong> \u2013 slo\u017eka TDF je \u00fa\u010dinn\u00e1 proti HBV<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed a pod\u00e1v\u00e1n\u00ed Tenvir-EM<\/h2>\n<table>\n<thead>\n<tr>\n<th>Sc\u00e9n\u00e1\u0159<\/th>\n<th>Doporu\u010den\u00e1 d\u00e1vka<\/th>\n<th>D\u00e9lka trv\u00e1n\u00ed \/ Pozn\u00e1mky<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Denn\u00ed PrEP (standardn\u00ed)<\/strong><\/td>\n<td>1 tableta 1x denn\u011b<\/td>\n<td>Neomezen\u011b, dokud p\u0159etrv\u00e1v\u00e1 riziko expozice; ide\u00e1ln\u011b ve stejnou denn\u00ed dobu<\/td>\n<\/tr>\n<tr>\n<td><strong>PrEP na vy\u017e\u00e1d\u00e1n\u00ed \u201c2-1-1\u201d (pouze pro MSM)<\/strong><\/td>\n<td>2 tablety 2\u201324 hodin p\u0159ed sexem; 1 tableta 24 hodin po; 1 tableta 48 hodin po<\/td>\n<td>Podle protokolu studie IPERGAY; pouze populace MSM, neov\u011b\u0159eno pro vagin\u00e1ln\u00ed sex<\/td>\n<\/tr>\n<tr>\n<td><strong>PEP (trojit\u00e1 terapie)<\/strong><\/td>\n<td>1 tableta denn\u011b + t\u0159et\u00ed l\u00e1tka<\/td>\n<td>Zah\u00e1jit do 72 hodin po expozici; 28denn\u00ed kurz<\/td>\n<\/tr>\n<tr>\n<td><strong>L\u00e9\u010dba HIV<\/strong><\/td>\n<td>1 tableta denn\u011b + t\u0159et\u00ed l\u00e1tka<\/td>\n<td>Do\u017eivotn\u00ed; adherence &gt;95% nutn\u00e1 pro trvalou virovou supresi<\/td>\n<\/tr>\n<tr>\n<td><strong>CrCl 30\u201349 ml\/min<\/strong><\/td>\n<td>1 tableta ka\u017ed\u00fdch 48 hodin<\/td>\n<td>Zkr\u00e1cen\u00fd interval d\u00e1vkov\u00e1n\u00ed<\/td>\n<\/tr>\n<tr>\n<td><strong>CrCl &lt;30 ml\/min nebo dial\u00fdza<\/strong><\/td>\n<td>Nedoporu\u010duje se<\/td>\n<td>P\u0159echod na p\u0159\u00edpravek obsahuj\u00edc\u00ed tenofovir alafenamid (TAF), nap\u0159\u00edklad <a href=\"https:\/\/medsbase.com\/cs\/tenvir-af\/\" rel=\"noopener\">Tenvir-AF<\/a><\/td>\n<\/tr>\n<tr>\n<td><strong>Porucha funkce jater<\/strong><\/td>\n<td>Standardn\u00ed d\u00e1vka<\/td>\n<td>Nen\u00ed t\u0159eba \u00fapravy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b u\u017e\u00edvat Tenvir-EM<\/h3>\n<ul>\n<li>Tabletu spolkn\u011bte celou s vodou; lze u\u017e\u00edvat s j\u00eddlem i bez j\u00eddla<\/li>\n<li>U\u017e\u00edvejte p\u0159ibli\u017en\u011b ve <strong>stejnou denn\u00ed dobu<\/strong> \u2014 vynechan\u00e9 d\u00e1vky sni\u017euj\u00ed ochranu<\/li>\n<li>P\u0159ed zah\u00e1jen\u00edm PrEP potvr\u010fte <strong>HIV-negativn\u00ed status<\/strong> pomoc\u00ed testu antigen\/protil\u00e1tka 4. generace a screeningu na <strong>hepatitidu B<\/strong> a <strong>kreatinin \/ eGFR<\/strong><\/li>\n<li>B\u011bhem u\u017e\u00edv\u00e1n\u00ed PrEP testujte na HIV ka\u017ed\u00e9 3 m\u011bs\u00edce, funkci ledvin ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f a pohlavn\u011b p\u0159enosn\u00e9 infekce alespo\u0148 ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f<\/li>\n<li>Nep\u0159est\u00e1vejte <strong>neu\u017e\u00edvejte Tenvir-EM samostatn\u011b jako l\u00e9\u010dbu HIV<\/strong> pokud jste HIV-pozitivn\u00ed \u2014 to m\u016f\u017ee v\u00e9st k v\u00fdb\u011bru rezistentn\u00edho viru. Je vy\u017eadov\u00e1n t\u0159et\u00ed l\u00e9k<\/li>\n<li>Pokud je d\u00e1vka PrEP vynech\u00e1na o m\u00e9n\u011b ne\u017e 24 hodin, u\u017eijte ji co nejd\u0159\u00edve. Pokud je vynech\u00e1na o v\u00edce ne\u017e 24 hodin, u\u017eijte dal\u0161\u00ed pl\u00e1novanou d\u00e1vku a pokra\u010dujte<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky Tenvir-EM<\/h2>\n<p>V\u011bt\u0161ina lid\u00ed sn\u00e1\u0161\u00ed Tenvir-EM dob\u0159e. Vedlej\u0161\u00ed \u00fa\u010dinky jsou obvykle m\u00edrn\u00e9 a zlep\u0161uj\u00ed se b\u011bhem 2\u20134 t\u00fddn\u016f od za\u010d\u00e1tku u\u017e\u00edv\u00e1n\u00ed tablety.<\/p>\n<table>\n<thead>\n<tr>\n<th>Z\u00e1va\u017enost<\/th>\n<th>Vedlej\u0161\u00ed \u00fa\u010dinek<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>B\u011b\u017en\u00e9 (\u22651 z 10)<\/strong><\/td>\n<td>Bolest hlavy, nevolnost, pr\u016fjem, \u00fanava \u2014 zejm\u00e9na v prvn\u00edch 2\u20134 t\u00fddnech (\u201cstart-up syndrom\u201d)<\/td>\n<\/tr>\n<tr>\n<td><strong>B\u011b\u017en\u00e9 (\u22651 ze 100)<\/strong><\/td>\n<td>Z\u00e1vrat\u011b, bolesti b\u0159icha, plynatost, m\u00edrn\u00e1 vyr\u00e1\u017eka, poruchy sp\u00e1nku, zv\u00fd\u0161en\u00e9 jatern\u00ed enzymy<\/td>\n<\/tr>\n<tr>\n<td><strong>M\u00e9n\u011b \u010dast\u00e9<\/strong><\/td>\n<td>Pokles funkce ledvin (vzestup kreatininu, proxim\u00e1ln\u00ed tubul\u00e1rn\u00ed dysfunkce, vz\u00e1cn\u011b Fanconiho syndrom), m\u00edrn\u00e9 sn\u00ed\u017een\u00ed kostn\u00ed miner\u00e1ln\u00ed denzity<\/td>\n<\/tr>\n<tr>\n<td><strong>Vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9<\/strong><\/td>\n<td>Lakt\u00e1tov\u00e1 acid\u00f3za s jatern\u00ed steat\u00f3zou (t\u0159\u00eddn\u00ed \u00fa\u010dinek NRTI), t\u011b\u017ek\u00e9 po\u0161kozen\u00ed ledvin, vzplanut\u00ed hepatitidy B po vysazen\u00ed u pacient\u016f s HBV<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Vyhledejte neodkladnou l\u00e9ka\u0159skou pomoc<\/strong> p\u0159i siln\u00e9 bolesti b\u0159icha se zvracen\u00edm, \u017eloutenkou, prudk\u00fdm poklesem mo\u010dov\u00e9ho v\u00fddeje, zmatenost\u00ed nebo rychl\u00fdm d\u00fdch\u00e1n\u00edm \u2014 to mohou b\u00fdt p\u0159\u00edznaky lakt\u00e1tov\u00e9 acid\u00f3zy, vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9 komplikace t\u0159\u00eddy NRTI.<\/p>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>Test na HIV p\u0159ed zah\u00e1jen\u00edm PrEP a b\u011bhem n\u011bj.<\/strong> Zah\u00e1jen\u00ed u\u017e\u00edv\u00e1n\u00ed Tenvir-EM (pouze dva l\u00e9ky) u n\u011bkoho s nediagnostikovan\u00fdm HIV m\u016f\u017ee v\u00e9st k rezistenci a ohrozit budouc\u00ed l\u00e9\u010dbu. Test na HIV 4. generace na za\u010d\u00e1tku a ka\u017ed\u00e9 3 m\u011bs\u00edce je nezbytn\u00fd<\/li>\n<li><strong>Funkce ledvin.<\/strong> TDF m\u016f\u017ee zp\u016fsobit d\u00e1vkov\u011b z\u00e1visl\u00e9 po\u0161kozen\u00ed ledvin. Kontrolujte eGFR na za\u010d\u00e1tku, po 3 m\u011bs\u00edc\u00edch, pot\u00e9 ka\u017ed\u00fdch 6\u201312 m\u011bs\u00edc\u016f. Vyhn\u011bte se u\u017e\u00edv\u00e1n\u00ed, pokud eGFR &lt;30 ml\/min<\/li>\n<li><strong>Zdrav\u00ed kost\u00ed.<\/strong> P\u0159i dlouhodob\u00e9m u\u017e\u00edv\u00e1n\u00ed TDF lze pozorovat m\u00edrn\u00e9 sn\u00ed\u017een\u00ed hustoty kostn\u00edch miner\u00e1l\u016f. Zva\u017ete dopl\u0148ov\u00e1n\u00ed v\u00e1pn\u00edku a vitaminu D.<\/li>\n<li><strong>Koinfekce hepatitidou B.<\/strong> Ukon\u010den\u00ed l\u00e9\u010dby p\u0159\u00edpravkem Tenvir-EM u osob s chronickou HBV m\u016f\u017ee vyvolat z\u00e1va\u017en\u00e9 zhor\u0161en\u00ed hepatitidy. Pokud je nutn\u00e9 l\u00e9\u010dbu ukon\u010dit, je t\u0159eba pe\u010dliv\u011b sledovat funkci jater.<\/li>\n<li><strong>Screening pohlavn\u011b p\u0159enosn\u00fdch infekc\u00ed.<\/strong> PrEP chr\u00e1n\u00ed p\u0159ed HIV, ale ne p\u0159ed jin\u00fdmi pohlavn\u011b p\u0159enosn\u00fdmi infekcemi \u2014 rutinn\u00ed screening na syfilis, kapavku a chlamydie z\u016fst\u00e1v\u00e1 d\u016fle\u017eit\u00fd.<\/li>\n<li><strong>T\u011bhotenstv\u00ed a kojen\u00ed.<\/strong> Tenvir-EM je pova\u017eov\u00e1n za bezpe\u010dn\u00fd v t\u011bhotenstv\u00ed jak pro l\u00e9\u010dbu, tak pro PrEP. Kojen\u00ed se nedoporu\u010duje u HIV pozitivn\u00edch \u017een (krom\u011b oblast\u00ed s n\u00edzk\u00fdmi zdroji podle doporu\u010den\u00ed WHO).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace \u2014 Kdo by NEM\u011aL u\u017e\u00edvat Tenvir-EM<\/h2>\n<ul>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na tenofovir disoproxil fumar\u00e1t, emtricitabin nebo jakoukoli pomocnou l\u00e1tku.<\/li>\n<li>Pou\u017eit\u00ed <strong>PrEP<\/strong> u osoby HIV-pozitivn\u00ed nebo s nezn\u00e1m\u00fdm HIV statusem<\/li>\n<li>T\u011b\u017ek\u00e9 ren\u00e1ln\u00ed posti\u017een\u00ed (CrCl &lt;30 ml\/min nebo na dial\u00fdze) \u2014 zva\u017ete p\u0159echod na kombinaci obsahuj\u00edc\u00ed tenofovir alafenamid (TAF), jako je <a href=\"https:\/\/medsbase.com\/cs\/tenvir-af\/\" rel=\"noopener\">Tenvir-AF<\/a><\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<table>\n<thead>\n<tr>\n<th>L\u00e9\u010divo \/ T\u0159\u00edda<\/th>\n<th>Interakce<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>NSAID (ibuprofen, diklofenak, naproxen)<\/strong><\/td>\n<td>Aditivn\u00ed nefrotoxicita \u2014 vyvarujte se chronick\u00e9ho pod\u00e1v\u00e1n\u00ed vysok\u00fdch d\u00e1vek NSAID<\/td>\n<\/tr>\n<tr>\n<td><strong>Aminoglykosidy, IV amfotericin B, IV vankomycin<\/strong><\/td>\n<td>V\u00fdznamn\u00e1 nefrotoxicita \u2014 pokud mo\u017eno se kombinaci vyhn\u011bte<\/td>\n<\/tr>\n<tr>\n<td><strong>Didanosin (ddI)<\/strong><\/td>\n<td>Nekombinujte \u2014 zvy\u0161uje hladiny ddI a toxicitu<\/td>\n<\/tr>\n<tr>\n<td><strong>Ledipasvir\/sofosbuvir (Harvoni) a dal\u0161\u00ed p\u0159\u00edm\u00e1 antivirotika proti HCV<\/strong><\/td>\n<td>M\u016f\u017ee zv\u00fd\u0161it hladiny tenofoviru \u2014 monitorujte ren\u00e1ln\u00ed funkci<\/td>\n<\/tr>\n<tr>\n<td><strong>Dal\u0161\u00ed NRTI obsahuj\u00edc\u00ed emtricitabin nebo lamivudin<\/strong><\/td>\n<td>Nadbyte\u010dn\u00e9 \u2014 nekombinujte<\/td>\n<\/tr>\n<tr>\n<td><strong>Re\u017eimy s ritonavirem jako boosterem<\/strong><\/td>\n<td>M\u00edrn\u00e9 zv\u00fd\u0161en\u00ed hladin tenofoviru \u2014 klinicky zvl\u00e1dnuteln\u00e9<\/td>\n<\/tr>\n<tr>\n<td><strong>T\u0159ezalka te\u010dkovan\u00e1<\/strong><\/td>\n<td>M\u00edrn\u011b sni\u017euje hladiny FTC a TDF; vyhn\u011bte se pou\u017eit\u00ed p\u0159i l\u00e9\u010db\u011b HIV<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>P\u0159ed zah\u00e1jen\u00edm u\u017e\u00edv\u00e1n\u00ed p\u0159\u00edpravku Tenvir-EM v\u017edy sd\u011blte sv\u00e9mu l\u00e9ka\u0159i \u00fapln\u00fd seznam p\u0159edepsan\u00fdch i voln\u011b prodejn\u00fdch l\u00e9k\u016f, v\u010detn\u011b rekrea\u010dn\u00edch drog a bylinn\u00fdch dopl\u0148k\u016f.<\/p>\n<h2 class=\"wp-block-heading\">Co d\u011blat v p\u0159\u00edpad\u011b p\u0159ed\u00e1vkov\u00e1n\u00ed<\/h2>\n<p>Akutn\u00ed p\u0159ed\u00e1vkov\u00e1n\u00ed TDF\/FTC je vz\u00e1cn\u00e9 a obvykle zp\u016fsobuje pouze gastrointestin\u00e1ln\u00ed p\u0159\u00edznaky. Ani jeden z l\u00e9k\u016f nen\u00ed v\u00fdznamn\u011b odstran\u011bn dial\u00fdzou. L\u00e9\u010dba je podp\u016frn\u00e1. Pokud m\u00e1te podez\u0159en\u00ed na v\u00fdznamn\u00e9 p\u0159ed\u00e1vkov\u00e1n\u00ed, okam\u017eit\u011b kontaktujte m\u00edstn\u00ed toxikologick\u00e9 st\u0159edisko nebo pohotovost.<\/p>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte pod 30 \u00b0C na such\u00e9m m\u00edst\u011b, mimo p\u0159\u00edm\u00e9 slune\u010dn\u00ed sv\u011btlo<\/li>\n<li>Uchov\u00e1vejte v p\u016fvodn\u00ed lahvi\u010dce nebo blistrov\u00e9m obalu<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed<\/li>\n<li>Nepou\u017e\u00edvejte po datu expirace uveden\u00e9m na obalu<\/li>\n<li>Nepou\u017eit\u00e9 tablety likvidujte prost\u0159ednictv\u00edm l\u00e9k\u00e1rny, pokud je k dispozici<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<p>Hled\u00e1te souvisej\u00edc\u00ed mo\u017enosti l\u00e9\u010dby PrEP nebo HIV?<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ricovir-em\/\" rel=\"noopener\">Ricovir EM<\/a> \u2014 p\u0159\u00edpravek TDF\/FTC od spole\u010dnosti Mylan, klinicky ekvivalentn\u00ed s Tenvir-EM<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tavin-em\/\" rel=\"noopener\">Tavin EM<\/a> \u2014 alternativa TDF\/FTC od spole\u010dnosti Hetero Labs<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tenof-em\/\" rel=\"noopener\">Tenof-EM<\/a> \u2014 dal\u0161\u00ed zna\u010dka TDF\/FTC<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tenvir-af\/\" rel=\"noopener\">Tenvir-AF<\/a> \u2014 <strong>tenofovir alafenamid (TAF) + FTC<\/strong>, nov\u011bj\u0161\u00ed alternativa s ni\u017e\u0161\u00ed ren\u00e1ln\u00ed a kostn\u00ed toxicitou<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tenvir\/\" rel=\"noopener\">Tenvir<\/a> \u2014 monoterapie tenofovirem 300 mg pro hepatitidu B<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tenvir-l\/\" rel=\"noopener\">Tenvir-L<\/a> \u2014 alternativa NRTI kombinace tenofovir + lamivudin (3TC)<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hiv-medication\/\" rel=\"noopener\">Prohl\u00e9dnout v\u0161echny l\u00e9ky na HIV \u2192<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Jak \u00fa\u010dinn\u00fd je Tenvir-EM jako PrEP?<\/h3>\n<p>P\u0159i pravideln\u00e9m denn\u00edm u\u017e\u00edv\u00e1n\u00ed podle p\u0159edpisu sni\u017euje PrEP s TDF\/FTC riziko sexu\u00e1ln\u00edho p\u0159enosu HIV o <strong>v\u00edce ne\u017e 99 %<\/strong>. \u00da\u010dinnost kles\u00e1 p\u0159i vynech\u00e1n\u00ed d\u00e1vek \u2013 zejm\u00e9na u vagin\u00e1ln\u00ed expozice, kde hladiny l\u00e9ku v tk\u00e1n\u00edch dosahuj\u00ed ochrann\u00fdch koncentrac\u00ed pomaleji.<\/p>\n<h3 class=\"wp-block-heading\">Jak dlouho trv\u00e1, ne\u017e Tenvir-EM za\u010dne fungovat jako PrEP?<\/h3>\n<p>Ochrann\u00e9 hladiny l\u00e9ku v <strong>rekt\u00e1ln\u00ed tk\u00e1ni<\/strong> jsou dosa\u017eeny p\u0159ibli\u017en\u011b po <strong>7 dnech<\/strong> denn\u00edm d\u00e1vkov\u00e1n\u00ed. Pro <strong>vagin\u00e1ln\u00ed tk\u00e1\u0148<\/strong>, povolit <strong>20 dn\u016f<\/strong>. CDC doporu\u010duje 7 dn\u00ed denn\u00edho u\u017e\u00edv\u00e1n\u00ed p\u0159ed spol\u00e9h\u00e1n\u00edm se na n\u011bj p\u0159i receptivn\u00edm an\u00e1ln\u00edm sexu a 20 dn\u00ed pro vagin\u00e1ln\u00ed nebo jin\u00e9 expozice.<\/p>\n<h3 class=\"wp-block-heading\">Mohu pou\u017e\u00edvat Tenvir-EM \u201cna vy\u017e\u00e1d\u00e1n\u00ed\u201d m\u00edsto denn\u011b?<\/h3>\n<p>Re\u017eim \u201c<strong>2-1-1<\/strong>\u201d na vy\u017e\u00e1d\u00e1n\u00ed (2 tablety 2\u201324 h p\u0159ed sexem, 1 tableta 24 h po, 1 tableta 48 h po) je podpo\u0159en studi\u00ed IPERGAY a je mo\u017enost\u00ed podle doporu\u010den\u00ed WHO a francouzsk\u00fdch sm\u011brnic <strong>pouze pro mu\u017ee, kte\u0159\u00ed maj\u00ed sex s mu\u017ei<\/strong>. Nebyl <em>ne<\/em> validov\u00e1n pro vagin\u00e1ln\u00ed sex, trans \u017eeny na feminiza\u010dn\u00edch hormonech nebo osoby u\u017e\u00edvaj\u00edc\u00ed injek\u010dn\u00ed drogy \u2014 denn\u00ed d\u00e1vkov\u00e1n\u00ed z\u016fst\u00e1v\u00e1 standardem mimo tuto specifickou populaci.<\/p>\n<h3 class=\"wp-block-heading\">Je Tenvir-EM stejn\u00fd jako Truvada?<\/h3>\n<p>Ano, pokud jde o \u00fa\u010dinn\u00e9 l\u00e1tky \u2014 oba obsahuj\u00ed tenofovir disoproxil fumar\u00e1t 300 mg a emtricitabin 200 mg. Tenvir-EM vyr\u00e1b\u00ed spole\u010dnost Cipla v Indii a je klinicky ekvivalentn\u00ed zna\u010dkov\u00e9mu Truvada od spole\u010dnosti Gilead<sup>\u00ae<\/sup>, za mnohem ni\u017e\u0161\u00ed cenu.<\/p>\n<h3 class=\"wp-block-heading\">Pot\u0159ebuji testov\u00e1n\u00ed na STI p\u0159i u\u017e\u00edv\u00e1n\u00ed PrEP?<\/h3>\n<p>Ano \u2014 Tenvir-EM chr\u00e1n\u00ed p\u0159ed HIV, ale ne p\u0159ed syfilis, kapavkou, chlamydiemi, HSV nebo jin\u00fdmi STI. D\u016frazn\u011b se doporu\u010duje rutinn\u00ed screening v intervalech 3\u20136 m\u011bs\u00edc\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Jak\u00e9 testy pot\u0159ebuji p\u0159ed zah\u00e1jen\u00edm PrEP?<\/h3>\n<p><strong>HIV<\/strong> (4. generace antigen\/protil\u00e1tkov\u00fd test), <strong>hepatitidu B<\/strong> (povrchov\u00fd antigen, protil\u00e1tka proti povrchov\u00e9mu antigenu, protil\u00e1tka proti j\u00e1drov\u00e9mu antigenu), <strong>kreatinin \/ eGFR<\/strong>, a ide\u00e1ln\u011b z\u00e1kladn\u00ed screening na pohlavn\u011b p\u0159enosn\u00e9 infekce. Pokud m\u00e1te chronickou hepatitidu B, Tenvir-EM je bezpe\u010dn\u00fd a \u010dasto prosp\u011b\u0161n\u00fd, ale vysazen\u00ed mus\u00ed b\u00fdt pe\u010dliv\u011b zvl\u00e1dnuto.<\/p>\n<h3 class=\"wp-block-heading\">Mohu pou\u017e\u00edt Tenvir-EM pro postexpozi\u010dn\u00ed profylaxi HIV (PEP)?<\/h3>\n<p>Ano \u2014 jako sou\u010d\u00e1st <strong>t\u0159\u00edl\u00e9kov\u00e9ho PEP re\u017eimu<\/strong>. Tenvir-EM dod\u00e1v\u00e1 dva NRTI; t\u0159et\u00ed l\u00e9k (obvykle dolutegravir nebo raltegravir) se p\u0159id\u00e1v\u00e1. PEP mus\u00ed b\u00fdt zah\u00e1jeno do 72 hodin po expozici, ide\u00e1ln\u011b do 24 hodin, a pokra\u010dovat po dobu 28 dn\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Co se stane, kdy\u017e vynech\u00e1m d\u00e1vku PrEP?<\/h3>\n<p>Pokud vynech\u00e1te d\u00e1vku o m\u00e9n\u011b ne\u017e 24 hodin, vezm\u011bte ji co nejd\u0159\u00edve. Pokud uplynulo v\u00edce ne\u017e 24 hodin, vynechanou d\u00e1vku p\u0159esko\u010dte a vezm\u011bte dal\u0161\u00ed pl\u00e1novanou. Ned\u00e1vejte dvojitou d\u00e1vku. Pokud vynech\u00e1te v\u00edce d\u00e1vek, ochrana je sn\u00ed\u017eena \u2014 restartujte 7- nebo 20denn\u00ed obdob\u00ed pro nasycen\u00ed tk\u00e1n\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Je Tenvir-EM bezpe\u010dn\u00fd pro m\u00e9 ledviny?<\/h3>\n<p>TDF m\u016f\u017ee zp\u016fsobit <strong>d\u00e1vkov\u011b z\u00e1visl\u00e9 \u00fa\u010dinky na ledviny<\/strong> u men\u0161iny u\u017eivatel\u016f. Je vy\u017eadov\u00e1no z\u00e1kladn\u00ed a pravideln\u00e9 sledov\u00e1n\u00ed eGFR. Pokud se ren\u00e1ln\u00ed funkce zhor\u0161\u00ed, nebo ji\u017e m\u00e1te CrCl &lt;30 ml\/min, p\u0159echod na nov\u011bj\u0161\u00ed <strong>tenofovir alafenamid (TAF)<\/strong> formulaci (nap\u0159. <a href=\"https:\/\/medsbase.com\/cs\/tenvir-af\/\" rel=\"noopener\">Tenvir-AF<\/a>) je preferov\u00e1n \u2014 TAF m\u00e1 v\u00fdrazn\u011b ni\u017e\u0161\u00ed ren\u00e1ln\u00ed a kostn\u00ed toxicitu.<\/p>\n<h3 class=\"wp-block-heading\">Mohu p\u0159estat u\u017e\u00edvat Tenvir-EM, pokud se zm\u011bn\u00ed m\u00e9 riziko HIV?<\/h3>\n<p>Ano \u2014 PrEP lze p\u0159eru\u0161it, kdy\u017e riziko klesne. Aktu\u00e1ln\u00ed doporu\u010den\u00ed je u\u017e\u00edvat Tenvir-EM po dobu <strong>7 dn\u00ed po va\u0161\u00ed posledn\u00ed expozici<\/strong> abyste zajistili, \u017ee jak\u00e1koli ned\u00e1vn\u00e1 expozice je pln\u011b pokryta. Pokud m\u00e1te chronickou hepatitidu B, nep\u0159est\u00e1vejte Tenvir-EM bez l\u00e9ka\u0159sk\u00e9ho dohledu kv\u016fli riziku vzplanut\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Interaguje Tenvir-EM s hormon\u00e1ln\u00ed antikoncepc\u00ed nebo feminizuj\u00edc\u00ed hormon\u00e1ln\u00ed terapi\u00ed?<\/h3>\n<p>Ne, neexistuje klinicky v\u00fdznamn\u00e1 interakce s kombinovanou nebo pouze gestagennou antikoncepc\u00ed nebo s feminizuj\u00edc\u00ed hormon\u00e1ln\u00ed terapi\u00ed (estradiol, cyproteron). Tenvir-EM nesni\u017euje \u00fa\u010dinnost antikoncepce.<\/p>\n<p><!-- medsbase-faq-h3-converted --><\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-prep-starter-pack\">Tavin EM (tenofovir disoproxil fumar\u00e1t 300 mg + emtricitabin 200 mg) je stejn\u00e9 slo\u017een\u00ed TDF\/FTC jako uv\u00e1d\u011bn\u00e9 ve studi\u00edch iPrEx, PROUD a Partners-PrEP. <a href='\/cs\/prep-starter-pack\/'>PrEP Starter Pack (Tenvir-EM + doxycyklin 100 mg)<\/a> Pokud nen\u00ed k dispozici nebo d\u00e1v\u00e1te p\u0159ednost jin\u00e9mu v\u00fdrobci pro v\u00e1\u0161 denn\u00ed re\u017eim PrEP,.<\/p>\n<p class=\"medsbase-link-boost-2026-05-21\" data-marker=\"mb-link-boost-tavin-em\">Pokud <a href=\"https:\/\/medsbase.com\/cs\/tenvir-em\/\">Tenvir EM<\/a> Tavin EM (tenofovir disoproxil fumar\u00e1t 300 mg + emtricitabin 200 mg) je stejn\u00e9 slo\u017een\u00ed TDF\/FTC jako uv\u00e1d\u011bn\u00e9 ve studi\u00edch iPrEx, PROUD a Partners-PrEP., <a href=\"https:\/\/medsbase.com\/cs\/tavin-em\/\">Tavin EM (tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg)<\/a> from Emcure Pharmaceuticals is the same TDF\/FTC composition cited in the iPrEx, PROUD and Partners-PrEP trials.<\/p>\n<p data-marker=\"mb-link-boost-taficita\" class=\"medsbase-link-boost-2026-05-25\">Mu\u017ei, kte\u0159\u00ed hledaj\u00ed alternativu s men\u0161\u00edm dopadem na ledviny k <a href=\"https:\/\/medsbase.com\/cs\/tenvir-em\/\">Tenvir-EM<\/a> (tenofovir disoproxil + emtricitabin) \u010dasto vol\u00ed <a href=\"https:\/\/medsbase.com\/cs\/taficita\/\">Taficita (tenofovir alafenamid 25 mg + emtricitabin 200 mg)<\/a> \u2014 re\u017eim PrEP zalo\u017een\u00fd na TAF se sn\u00ed\u017een\u00fdmi \u00fa\u010dinky na ledviny a hustotu kost\u00ed.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 id=\"related-alts\">Dal\u0161\u00ed l\u00e9ky na sexu\u00e1ln\u00ed zdrav\u00ed<\/h2>\n<ul>\n<li><a href=\"\/cs\/ricovir-em\/\">Ricovir EM (TDF\/FTC 300+200 mg)<\/a><\/li>\n<li><a href=\"\/cs\/tenof-em\/\">Tenof EM (TDF\/FTC 300+200 mg)<\/a><\/li>\n<li><a href=\"\/cs\/tavin-em\/\">Tavin EM (TDF\/FTC 300+200 mg)<\/a><\/li>\n<li><a href=\"\/cs\/taficita\/\">Taficita (TAF\/FTC 25+200 mg, generikum Descovy)<\/a><\/li>\n<li><a href=\"\/cs\/std-protection-pack\/\">Bal\u00ed\u010dek ochrany proti STD<\/a><\/li>\n<\/ul>\n<p style=\"font-size:13px;color:#555;margin:14px 0;font-style:italic;\"><strong>Zdravotn\u00ed upozorn\u011bn\u00ed:<\/strong> Informace na t\u00e9to str\u00e1nce slou\u017e\u00ed pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nenahrazuj\u00ed l\u00e9ka\u0159skou pomoc. P\u0159ed zah\u00e1jen\u00edm, ukon\u010den\u00edm nebo zm\u011bnou jak\u00e9hokoli l\u00e9ku se v\u017edy pora\u010fte s kvalifikovan\u00fdm l\u00e9ka\u0159em.<\/p>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Chr\u00e1n\u00ed p\u0159ed infekc\u00ed HIV<br \/>\n\u2705 Zabra\u0148uje mno\u017een\u00ed viru<br \/>\n\u2705 Potenci\u00e1l pro l\u00e9\u010dbu hepatitidy B<br \/>\n\u2705 Zlep\u0161uje kvalitu \u017eivota<br \/>\n\u2705 Generick\u00e1 verze p\u0159\u00edpravku Truvada \u00ae<\/h5>\n<p><span style=\"color: #999999;\"><strong>Tenvir Em<\/strong> obsahuje <strong>Emtricitabine<\/strong> a <strong>Tenofovir.<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"featured_media":51177,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3334,3304,3338,3337],"product_tag":[5675,3339,5674,5676,5672,5671,5673,3335,3340,5670],"class_list":{"0":"post-51176","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-hepatitis-medication","9":"product_cat-hiv-medication","10":"product_cat-prep-medication-pre-exposure-prophylaxis","11":"product_cat-sexual-health","12":"product_tag-antiretroviral","13":"product_tag-emtricitabine","14":"product_tag-ftc","15":"product_tag-hepatitis-b","16":"product_tag-hiv-pep","17":"product_tag-hiv-prep","18":"product_tag-tdf","19":"product_tag-tenofovir","20":"product_tag-tenvir-em","21":"product_tag-truvada-generic","23":"first","24":"instock","25":"featured","26":"shipping-taxable","27":"purchasable","28":"product-type-variable","29":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/51176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=51176"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/51177"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=51176"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=51176"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=51176"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=51176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}